Study of the V3 loop as a target epitope for antibodies involved in the neutralization of primary isolates versus T-cell-line-adapted strains of human immunodeficiency virus type 1
about
Neutralization of tier-2 viruses and epitope profiling of plasma antibodies from human immunodeficiency virus type 1 infected donors from IndiaCryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.Induction of antibodies in guinea pigs and rhesus monkeys against the human immunodeficiency virus type 1 envelope: neutralization of nonpathogenic and pathogenic primary isolate simian/human immunodeficiency virus strains.Identification of gp120 regions targeted by a highly potent neutralizing antiserum elicited in a chimpanzee inoculated with a primary human immunodeficiency virus type 1 isolateA cell line-based neutralization assay for primary human immunodeficiency virus type 1 isolates that use either the CCR5 or the CXCR4 coreceptor.Characterization of primary isolate-like variants of simian-human immunodeficiency virusVaccine-elicited V3 loop-specific antibodies in rhesus monkeys and control of a simian-human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate envelopeInduction of neutralizing antibodies and gag-specific cellular immune responses to an R5 primary isolate of human immunodeficiency virus type 1 in rhesus macaques.Antibody-mediated neutralization of primary human immunodeficiency virus type 1 isolates: investigation of the mechanism of inhibition.Ability of the V3 loop of simian immunodeficiency virus to serve as a target for antibody-mediated neutralization: correlation of neutralization sensitivity, growth in macrophages, and decreased dependence on CD4Immunoglobulin G (IgG) and IgA, but also nonantibody factors, account for in vitro neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by serum and plasma of HIV-infected patients.Neutralizing antibodies against HIV-1: can we elicit them with vaccines and how much do we need?Neutralizing antibody responses in recent seroconverters with HIV-1 subtype C infections in India.Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from various clades.Regional clustering of shared neutralization determinants on primary isolates of clade C human immunodeficiency virus type 1 from South Africa.Efficient inhibition of HIV-1 replication in human immature monocyte-derived dendritic cells by purified anti-HIV-1 IgG without induction of maturation.Characterization and Implementation of a Diverse Simian Immunodeficiency Virus SIVsm Envelope Panel in the Assessment of Neutralizing Antibody Breadth Elicited in Rhesus Macaques by Multimodal Vaccines Expressing the SIVmac239 Envelope.Polyclonal immunoglobulin G from patients neutralizes human immunodeficiency virus type 1 primary isolates by binding free virions, but without interfering with an initial CD4-independent attachment of the virus to primary blood mononuclear cells.Soluble CD4 broadens neutralization of V3-directed monoclonal antibodies and guinea pig vaccine sera against HIV-1 subtype B and C reference viruses.Specific sequences commonly found in the V3 domain of HIV-1 subtype C isolates affect the overall conformation of native Env and induce a neutralization-resistant phenotype independent of V1/V2 masking.Antibodies that are cross-reactive for human immunodeficiency virus type 1 clade a and clade B v3 domains are common in patient sera from Cameroon, but their neutralization activity is usually restricted by epitope masking.Induction and characterization of neutralizing antibodies against a human immunodeficiency virus type 1 primary isolate.Conservation of human immunodeficiency virus type 1 gp120 inner-domain sequences in lentivirus and type A and B retrovirus envelope surface glycoproteins.Maternal Binding and Neutralizing IgG Responses Targeting the C-Terminal Region of the V3 Loop Are Predictive of Reduced Peripartum HIV-1 Transmission RiskNeutralization tiers of HIV-1.
P2860
Q28483205-56A03E4C-81E8-4679-ABEE-DFBACE152DDEQ33788810-8D4B53D2-96D9-4B38-8503-D7FA51DA4B7BQ33794744-C405E2A7-7088-4397-B7E2-B261C83EA656Q33811940-17D42E8E-46BE-4F8E-BAB2-C1AA9B88E6F9Q33822395-B49C5717-6241-473C-844C-109CBA1D98D7Q33825229-7CA1ACCE-6C83-4F87-9BB1-B058111E28C2Q33839402-1611AFEC-6334-48B7-B4C8-41D8642AA599Q33842286-B968537E-E13E-4EC3-839E-D5C1DFD590C6Q33850612-24420CB6-21F5-452A-B6CB-EEED7F413CEDQ33851405-2A15D416-6CDA-4FBD-AB7F-B8C0AE7EC4FFQ33852361-FCC8EA33-2703-4187-A938-CDFCA18BC533Q33887693-2F4D9D71-BFB0-4E62-AC9D-53887438D6DDQ34083235-0A36D594-7583-41C4-836D-CF641DFE01F9Q34145199-7B20A2B5-6C9F-4A43-82D1-7A90F118737AQ34332009-486AD606-BD61-440C-8E20-4F402365CF4FQ35849709-D83F12D1-7677-4FD2-B480-2AE6ED2A4373Q35914362-4F96F33C-194E-4A1A-A4E7-1365557084CEQ36541239-E3D52415-ABD2-418E-820C-81AB49D9C0DDQ37084521-C4EFDCEE-E258-43F6-9306-DC7F18845643Q37554149-A74EFFCD-FC8B-4F97-8D18-F12D68E445FBQ37744047-F55DE972-A4A8-473A-B82E-7F4805799628Q39603619-1B83D7FE-E5A8-4D7E-B69E-78087A7ADAD4Q39607240-19668753-0556-4EC0-AA9E-5E8E7414828EQ40331385-DB01AFFF-850B-4606-B103-9374D4606355Q47562235-AE6DB940-E581-4DFD-94BD-1DA708A46FCC
P2860
Study of the V3 loop as a target epitope for antibodies involved in the neutralization of primary isolates versus T-cell-line-adapted strains of human immunodeficiency virus type 1
description
1998 nî lūn-bûn
@nan
1998 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Study of the V3 loop as a targ ...... immunodeficiency virus type 1
@ast
Study of the V3 loop as a targ ...... immunodeficiency virus type 1
@en
type
label
Study of the V3 loop as a targ ...... immunodeficiency virus type 1
@ast
Study of the V3 loop as a targ ...... immunodeficiency virus type 1
@en
prefLabel
Study of the V3 loop as a targ ...... immunodeficiency virus type 1
@ast
Study of the V3 loop as a targ ...... immunodeficiency virus type 1
@en
P2093
P2860
P1433
P1476
Study of the V3 loop as a targ ...... immunodeficiency virus type 1
@en
P2093
P2860
P304
P577
1998-12-01T00:00:00Z